Johnson & Johnson
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 15% of the universe, above its 200-day average.
- Signal has read BUY for 5 months.
- Its last 3 Buy calls have averaged +4% over the following quarter.
- Recent price momentum is +29.6% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 0.7% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2855 U.S. stocks StockVane covers.
Last computed: 2026-11-14 20:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation D-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 43.4x | Better than 14% |
| Forward P/E | 27.4x | Better than 23% |
| Price / Sales | 6.6x | Better than 17% |
| P/E vs own 5-yr range | 100th pctl | Better than 1% |
Growth B
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 5.6% | Better than 49% |
| Net income CAGR (3Y) | 14.3% | Better than 65% |
| Free cash flow CAGR (3Y) | 4.0% | Better than 43% |
Profitability A+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 67.9% | Better than 81% |
| Operating margin | 27.2% | Better than 87% |
| Net margin | 28.5% | Better than 88% |
| Return on equity | 35.0% | Better than 90% |
| Return on invested capital | 22.5% | Better than 92% |
Momentum A
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 10.3% | Better than 84% |
| 6-month return | 27.4% | Better than 82% |
| 12-month return (ex latest month) | 32.2% | Better than 73% |
| Distance below 52-week high | 0.8% | Better than 98% |
Financial Health C+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.0x | Better than 20% |
| Debt to assets | 24.1% | Better than 50% |
| Interest coverage | 34.6x | Better than 88% |
| Free cash flow / net income | 72.1% | Better than 22% |
Analyst View C-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 68.8% | Better than 47% |
| Upside to average target | 1.4% | Better than 12% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 283.52
- Open
- 285.00
- Day range
- 281.68 - 288.11
- Avg price
- 286.08
- Volume
- 6.29M
- Turnover
- 1.80B
- Turnover ratei
- 0.26%
- Volume ratioi
- 0.82
- Amplitudei
- 2.27%
- 52-week rangei
- 191.58 - 288.11
Valuation
- P/Ei
- 25.91
- P/E (TTM)i
- 43.43
- P/Bi
- 8.44
- EPSi
- 11.03
- Book value / shi
- 33.87
- Net profit
- 26.55B
- Net assets
- 81.53B
Share structure
- Market cap
- 687.89B
- Float capi
- 687.50B
- Shares out
- 2.41B
- Float sharesi
- 2.41B
Dividend & listing
- Div yield (TTM)i
- 1.85%
- Dividend (TTM)
- 5.28
- Listing date
- 1970-01-01
0.8% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-394.95M net over the window
Short interest
- Shares short
- 16.77M
- % of floati
- 0.70%
- Days to coveri
- 1.97
- As of
- 2026-10-15
Frequently asked questions
What is the current stock price of Johnson & Johnson (JNJ)?
Johnson & Johnson last traded at 285.75. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Johnson & Johnson's market cap?
About 687.89B.
What is the P/E ratio of Johnson & Johnson?
The trailing twelve-month P/E is 43.43, above its own 5-year average of 22.20 — toward the top of its historical range (99.92% percentile). See the Valuation tab for the full history.
Does Johnson & Johnson pay a dividend?
Yes. The trailing dividend yield is 1.85%. The 2025 payout was up 4.7% from 2024. See the Dividends tab for the full payment history.
Is Johnson & Johnson a buy according to analysts?
The consensus of 16 analysts is a Buy rating, with an average 12-month price target of 289.73, which implies 1.4% upside from the current price. This is not investment advice.
What is Johnson & Johnson's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Johnson & Johnson a B (Buy). Twelve-month momentum in the top 15% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-11-13 20:01:17 · For reference only, not investment advice and not tailored to your situation.
talc litigation headlines still spook this stock every few months but the pharma pipeline keeps quietly delivering. slow and steady, exactly how I like my healthcare names.